Hydrocortisone therapy for patients with septic shock
In patients with septic shock, the administration of corticosteroids leads to faster resolution of shock but has no effect on mortality at 28 days or at one year.
Level of evidence: 1 + (RCT with a low risk of bias) Time to resolution of shock variable 6.0 3.9 <0.001 (95% CI 4.9 to 9.0) (95% CI 3.0 to 5.2)
Appraised by: Kevin Sim

Non-event outcomes Time to outcome/s Control group Experimental group P-value
Time to resolution of shock variable 5.8 days 3.3 days <0.001 (95% CI 5.2 to 6.9) (95% CI 2.9 to 3.9)
The evidence:
Results in non-responders to corticotropin 250 micrograms (defined as an increase of less than 248 nmol/L) In view of the lack of efficacy and possible increase in adverse effects, if you currently use corticosteroids routinely in patients with septic shock or following a synacthen test you should review your practice. It may be appropriate to continue using steroid therapy "in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy" as stated in the surviving sepsis criteria. This would match the patient sub group identified as benefiting from steroids by Annane (JAMA, 2002) .
Should I audit my current practice because of these results?
Yes. If you use corticosteroids in septic shock you should audit your rate of complications associated with this. 
